• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by BlueRiver Acquisition Corp.

    2/6/24 6:08:57 AM ET
    $BLUA
    Blank Checks
    Finance
    Get the next $BLUA alert in real time by email
    SC 13G 1 d757868dsc13g.htm SC 13G SC 13G

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

     

    BlueRiver Acquisition Corp.

    G1261Q107

    (CUSIP Number)

    February 1, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

      ☐

    Rule 13d-1(b)

     

      ☒

    Rule 13d-1(c)

     

      ☐

    Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    Continued on following pages

    Page 1 of 11 Pages

    Exhibit Index: 10 Page

     

     

     


    CUSIP No. G1261Q107       Page 2 of 11 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Harraden Circle Investments, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     150,000

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     150,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     150,000

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     5.61%

    12  

     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

     OO, HC, IA


    CUSIP No. G1261Q107       Page 3 of 11 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Harraden Circle Investors GP, LP

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     128,288

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     128,288

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     128,288

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     4.80%

    12  

     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

     PN, HC


    CUSIP No. G1261Q107       Page 4 of 11 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Harraden Circle Investors GP, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     128,288

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     128,288

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     128,288

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     4.80%

    12  

     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

     OO, HC

     


    CUSIP No. G1261Q107       Page 5 of 11 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Harraden Circle Investors, LP

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     128,288

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     128,288

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     128,288

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     4.80%

    12  

     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

     PN


    CUSIP No. G1261Q107       Page 6 of 11 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Harraden Circle Special Opportunities, LP

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     0

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     0

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     0

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0%

    12  

     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

     PN


    CUSIP No. G1261Q107       Page 7 of 11 Pages

     

     1   

     NAMES OF REPORTING PERSONS

     

     Frederick V. Fortmiller, Jr.

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☐

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES  BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

     SOLE VOTING POWER

     

     0

       6   

     SHARED VOTING POWER

     

     150,000

       7   

     SOLE DISPOSITIVE POWER

     

     0

       8   

     SHARED DISPOSITIVE POWER

     

     150,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     150,000

    10  

     CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     5.61%

    12  

     TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

     IN, HC


    CUSIP No. G1261Q107       Page 8 of 11 Pages

     

    Item 1(a).

    Name of Issuer

    BlueRiver Acquisition Corp. (the “issuer”)

     

    Item 1(b).

    Address of Issuer’s Principal Executive Offices

    250 West Nottingham Drive, Suite 400, San Antonio, TX 78209

     

    Item 2(a).

    Names of Persons Filing

    This Statement is filed on behalf of the following persons (collectively, the “Reporting Persons”):

     

      i)

    Harraden Circle Investors, LP (“Harraden Fund”),

     

      ii)

    Harraden Circle Special Opportunities, LP (“Harraden Special Op Fund”)

     

      iii)

    Harraden Circle Investors GP, LP (“Harraden GP”);

     

      iv)

    Harraden Circle Investors GP, LLC (“Harraden LLC”);

     

      v)

    Harraden Circle Investments, LLC (“Harraden Adviser”); and

     

      vi)

    Frederick V. Fortmiller, Jr. (“Mr. Fortmiller”);

    This Statement relates to Shares (as defined herein) directly beneficially owned by Harraden Fund and Harraden Special Op Fund, Harraden GP is the general partner to Harraden Fund and Harraden Special Op Fund, and Harraden LLC is the general partner of Harraden GP. Harraden Adviser serves as investment manager to Harraden Fund, Harraden Special Op Fund and other high net worth individuals. Mr. Fortmiller is the managing member of each of Harraden LLC and Harraden Adviser. In such capacities, each of Harraden GP, Harraden LLC, Harraden Adviser and Mr. Fortmiller may be deemed to indirectly beneficially own the Shares reported herein directly beneficially owned by Harraden Fund and Harraden Special Op Fund.

     

    Item 2(b).

    Address of Principal Business Office or, if None, Residence

    The address of the principal business office of each Reporting Person is 299 Park Avenue, 21st Floor, New York, NY 10171.

     

    Item 2(c).

    Citizenship

    Each of Harraden Fund, Harraden Special Op Fund and Harraden GP is a Delaware limited partnership. Each of Harraden LLC and Harraden Adviser is a Delaware limited liability company. Mr. Fortmiller is a citizen of the United States of America.

     

    Item 2(d).

    Title of Class of Securities

    Class A Common Stock, par value $0.0001 per share (“Shares”)

     

    Item 2(e).

    CUSIP No. G1261Q107

    Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: This Item 3 is not applicable.


    CUSIP No. G1261Q107       Page 9 of 11 Pages

     

    Item 4.

    Ownership

     

    Item 4(a)

    Amount Beneficially Owned

    As of February 6, 2024, each of the Reporting Persons may be deemed the beneficial owner of 150,000 Shares underlying Units held directly by Harraden Fund, Harraden Special Op Fund and Harraden Adviser.

     

    Item 4(b)

    Percent of Class Fund and Harraden Adviser.

    As of February 6, 2024, each of the Reporting Persons may be deemed the beneficial owner of approximately 5.61% of Shares outstanding. This percentage is based on a total of 2,672,928 Shares outstanding, based on information in the Form DEF14A filed by the Company on February 1, 2024.

     

    Item 4(c)

    Number of shares as to which such person has:

     

    (i) Sole power to vote or direct the vote:

         0  

    (ii) Shared power to vote or direct the vote:

         150,000  

    (iii) Sole power to dispose or direct the disposition of:

         0  

    (iv) Shared power to dispose or direct the disposition of:

         150,000  

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    This Item 5 is not applicable.

     

    Item 6.

    Ownership of More than Five Percent on Behalf of Another Person

    This Item 6 is not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

    See disclosure in Item 2 hereof.

     

    Item 8.

    Identification and Classification of Members of the Group

    This Item 8 is not applicable.

     

    Item 9.

    Notice of Dissolution of Group

    This Item 9 is not applicable.

     

    Item 10.

    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    CUSIP No. G1261Q107       Page 10 of 11 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Date: February 6, 2024

     

    HARRADEN CIRCLE INVESTORS, LP
    HARRADEN CIRCLE SPECIAL OPPORTUNITIES, LP
    By:   HARRADEN CIRCLE INVESTORS GP, LP, its general partner
    By:   HARRADEN CIRCLE INVESTORS GP, LLC, its general partner
    By:  

    /s/ Frederick V. Fortmiller, Jr.

    Title:   Managing Member
    HARRADEN CIRCLE INVESTORS GP, LP
    By:   HARRADEN CIRCLE INVESTORS GP, LLC, its general partner
    By:  

    /s/ Frederick V. Fortmiller, Jr.

    Title:   Managing Member
    HARRADEN CIRCLE INVESTORS GP, LLC
    By:  

    /s/ Frederick V. Fortmiller, Jr.

      Managing Member
    HARRADEN CIRCLE INVESTMENTS, LLC
    By:  

    /s/ Frederick V. Fortmiller, Jr.

      Managing Member
    FREDERICK V. FORTMILLER, JR.

    /s/ Frederick V. Fortmiller, Jr.


    CUSIP No. G1261Q107       Page 11 of 11 Pages

     

    Exhibit INDEX

     

    Joint Filing Agreement

         11  
    Get the next $BLUA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BLUA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BLUA
    SEC Filings

    See more
    • SEC Form 425 filed by BlueRiver Acquisition Corp.

      425 - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/6/24 4:54:23 PM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - BlueRiver Acquisition Corp. (0001831006) (Filer)

      8/6/24 4:51:44 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form DEF 14A filed by BlueRiver Acquisition Corp.

      DEF 14A - BlueRiver Acquisition Corp. (0001831006) (Filer)

      7/26/24 4:36:22 PM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by BlueRiver Acquisition Corp.

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      8/9/24 2:47:16 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G/A filed by BlueRiver Acquisition Corp. (Amendment)

      SC 13G/A - BlueRiver Acquisition Corp. (0001831006) (Subject)

      5/10/24 4:21:54 PM ET
      $BLUA
      Blank Checks
      Finance
    • SEC Form SC 13G filed by BlueRiver Acquisition Corp.

      SC 13G - BlueRiver Acquisition Corp. (0001831006) (Subject)

      3/11/24 7:49:12 PM ET
      $BLUA
      Blank Checks
      Finance

    $BLUA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NYSE American to Suspend Trading in BlueRiver Acquisition Corp. (BLUA)

      NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to suspend trading in the Class A ordinary shares (NYSE:BLUA) and units (NYSE:BLUA) of BlueRiver Acquisition Corp. (the "Company") from NYSE American. The NYSE American had previously announced on February 2, 2024 an NYSE Regulation determination to delist all of the Company's listed securities, which included Company's Class A ordinary shares, units and redeemable warrants (collectively, "Securities"), and the Company appealed such delisting determination. On July 3, 2024, the NYSE American suspended trading in the Company's redeemable warrants as they were trading at an a

      7/15/24 9:15:00 AM ET
      $BLUA
      Blank Checks
      Finance
    • BlueRiver Acquisition Corp. Receives Commencement of Delisting Notice From NYSE American; Announces Extension of Merger Agreement

      BlueRiver Acquisition Corp. (NYSE:BLUA) (the "Company") announces that, as disclosed in the Company's Current Report on Form 8-K filed on February 7, 2024 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC ("NYSE American" or the "Exchange") on February 2, 2024, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company's Common Stock, Units and Rights (collectively, the "Securities") pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because the Company failed to consummate a business combination within 36 months of the effectiveness of its initial public offe

      2/7/24 5:58:00 PM ET
      $BLUA
      Blank Checks
      Finance
    • Spinal Stabilization Technologies, LLC, a Leading Developer and Manufacturer of Spinal Medical Devices, to be Publicly Listed through a Proposed Business Combination with BlueRiver Acquisition Corp.

      Spinal Stabilization Technologies is a pioneer in developing minimally invasive surgical treatments for specific types of lower back pain. It is targeting a promising market opportunity within the areas of Augmented Discectomy and Degenerative Disc Disease. In March 2021, the FDA granted the PerQdisc Nucleus Replacement System, the Company's leading product candidate, designation as a Breakthrough Device, potentially allowing for a more streamlined FDA review process and reduced regulatory costs. Proposed transaction represents a pre-money equity value of $240 million for Spinal Stabilization Technologies. Existing Spinal Stabilization Technologies shareholders will roll 100% o

      7/24/23 5:04:00 AM ET
      $BLUA
      Blank Checks
      Finance